Ownership and insider activity for None (BLRX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
BioLineRx Ltd., an Israeli biopharmaceutical firm established in 2003 and based in Hevel Modi'in, focuses its clinical-stage development efforts primarily on oncology. Their leading investigational product, Motixafortide, a peptide, has successfully concluded pivotal Phase 3 clinical trials for mobilizing stem cells in autologous transplants, and Phase 2a trials targeting pancreatic cancer.
Price
| Price | $2.48 |
| Market Cap | $11M |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-03-18 | Yan Shaoyu | |||
| 2016-10-05 | PANEM SANDRA | 49,800 | $42K | |
| 2017-10-05 | PANEM SANDRA | 19,800 | $18K | |
| 2018-10-05 | PANEM SANDRA | 19,800 | $18K | |
| 2019-10-02 | PANEM SANDRA | 199,800 | $71K | |
| 2020-10-02 | PANEM SANDRA | 79,800 | $29K | |
| 2021-10-02 | PANEM SANDRA | 79,800 | $31K | |
| 2024-10-03 | PANEM SANDRA | 360,000 | $31K | |
| 2023-10-03 | PANEM SANDRA | 360,000 | $29K | |
| 2025-01-01 | PANEM SANDRA | 2,055,000 | $107K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.5M | $5.1M | $3.4M | $5.3M | $16.8M | $13.0M | $10.6M | $4.3M | $10.4M | $3.2M |
| Short-term Investments | $33.2M | $44.4M | $26.7M | $22.2M | $5.8M | $44.1M | $40.5M | $38.7M | $9.1M | $17.6M |
| Receivables | $223000 | $586000 | $1.3M | $613000 | $141000 | $142000 | $721000 | $708000 | $3.9M | $455992 |
| Inventory | 0 | 0 | 0 | $107279 | 0 | $126731 | $197081 | $2.0M | $3.1M | $2.1M |
| Total Current Assets | $36.1M | $50.4M | $32.0M | $28.2M | $22.9M | $57.4M | $52.0M | $47.2M | $27.1M | $23.7M |
| Property, Plant & Equipment | $2.6M | $2.5M | $2.2M | $3.5M | $2.7M | $2.3M | $2.5M | $1.9M | $1.4M | $855986 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $181000 | $7.0M | $22.0M | $21.9M | $21.7M | $21.7M | $21.9M | $14.9M | $10.4M | $16.4M |
| Total Assets | $38.9M | $61.0M | $56.2M | $53.6M | $47.3M | $81.4M | $76.4M | $63.9M | $38.9M | $40.9M |
| Accounts Payable | $2.6M | $5.5M | $4.5M | $7.8M | $5.9M | $5.6M | $7.0M | $10.9M | $5.6M | $3.5M |
| Short-term Debt | $93000 | $93000 | $895000 | $2.7M | $3.1M | $2.8M | $1.5M | $3.1M | $4.5M | $4.7M |
| Total Current Liabilities | $3.7M | $6.7M | $6.8M | $12.0M | $10.6M | $9.7M | $10.7M | $42.8M | $15.4M | $12.1M |
| Long-term Debt | $250000 | $157000 | $7.8M | $5.8M | $2.7M | 0 | $8.6M | $6.6M | $9.0M | $4.5M |
| Total Liabilities | $3.9M | $8.1M | $14.9M | $20.2M | $25.3M | $13.3M | $25.5M | $50.7M | $25.4M | $17.6M |
| Retained Earnings | -$175.2M | -$199.6M | -$222.5M | -$248.0M | -$278.0M | -$305.0M | -$330.0M | -$390.6M | -$399.8M | -$401.0M |
| Total Equity | $35.0M | $52.9M | $41.3M | $33.4M | $22.0M | $68.1M | $50.8M | $13.2M | $13.5M | $18.2M |
| Total Debt | $343000 | $250000 | $8.7M | $10.5M | $7.7M | $4.7M | $12.3M | $11.6M | $15.0M | $10.1M |
| Net Debt | -$35.3M | -$49.2M | -$21.4M | -$17.0M | -$14.9M | -$52.5M | -$38.8M | -$31.4M | -$4.5M | -$10.7M |
| Working Capital | $32.4M | $43.7M | $25.2M | $16.2M | $12.2M | $47.7M | $41.3M | $4.4M | $11.7M | $11.6M |
Related companies: ADAP · ADTX · AIMD · ANL · APLM · GOVX · ICU
More sections of BLRX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks